Sophie Therese Williams

Sophie Therese Williams

Auto-generated profile, based on publicly available information

Sophie Therese Williams

Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
HLHaonan Lu
Haonan Lu
MAMubarik Arshad
Mubarik Arshad
ATAndrew Thornton
Andrew Thornton
GAGiacomo Avesani
Giacomo Avesani
PCPaula Cunnea
Paula Cunnea
EAEric Ofori Aboagye
Eric Ofori Aboagye
The five-year survival rate of epithelial ovarian cancer (EOC) is approximately 35–40% despite maximal treatment efforts, highlighting a need for stratification biomarkers for personalized treatment. Here we extract 657 quantitative mathematical descriptors from the preoperative CT images of 364 EOC patients at their initial presentation. Using machine learning, we derive a non-invasive summary-statistic of the primary ovarian tumor based on 4 descriptors, which we name “Radiomic Prognostic Vector” (RPV). RPV reliably identifies the 5% of patients with median overall survival less than 2 years, significantly improves established prognostic methods, and is validated in two independent, multi-center cohorts. Furthermore, genetic, transcriptomic and proteomic analysis from two independent datasets elucidate that stromal phenotype and DNA damage response pathways are activated in RPV-stratified tumors. RPV and its associated analysis platform could be exploited to guide personalized therapy of EOC and is potentially transferrable to other cancer types.

2 December 2014 in Epigenetics
Verified
Journal Article
Open access
SWSophie T Williams
Sophie T Williams
LWLouise J Walport
Louise J Walport
RHRichard J Hopkinson
Richard J Hopkinson
SMSarah K Madden
Sarah K Madden
RCRasheduzzaman Chowdhury
Rasheduzzaman Chowdhury
AKAkane Kawamura
Akane Kawamura
The JmjC-domain-containing 2-oxoglutarate-dependent oxygenases catalyze protein hydroxylation and Nϵ-methyllysine demethylation via hydroxylation. A subgroup of this family, the JmjC lysine demethylases (JmjC KDMs) are involved in histone modifications at multiple sites. There are conflicting reports as to the substrate selectivity of some JmjC oxygenases with respect to KDM activities. In this study, a panel of modified histone H3 peptides was tested for demethylation against 15 human JmjC-domain-containing proteins. The results largely confirmed known Nϵ-methyllysine substrates. However, the purified KDM4 catalytic domains showed greater substrate promiscuity than previously reported (i.e., KDM4A was observed to catalyze demethylation at H3K27 as well as H3K9/K36). Crystallographic analyses revealed that the Nϵ-methyllysine of an H3K27me3 peptide binds similarly to Nϵ-methyllysines of H3K9me3/H3K36me3 with KDM4A. A subgroup of JmjC proteins known to catalyze hydroxylation did not display demethylation a...

3 November 2011 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
GHGemma L. Holliday
Gemma L. Holliday
Claudia AndreiniClaudia Andreini
Claudia Andreini
JFJulia D. Fischer
Julia D. Fischer
SRSyed Asad Rahman
Syed Asad Rahman
Daniel E AlmonacidDaniel E Almonacid
Daniel E Almonacid
WPWilliam R. Pearson
William R. Pearson
MACiE (which stands for Mechanism, Annotation and Classification in Enzymes) is a database of enzyme reaction mechanisms, and can be accessed from http://www.ebi.ac.uk/thornton-srv/databases/MACiE/. This article presents the release of Version 3 of MACiE, which not only extends the dataset to 335 entries, covering 182 of the EC sub-subclasses with a crystal structure available (∼90%), but also incorporates greater chemical and structural detail. This version of MACiE represents a shift in emphasis for new entries, from non-homologous representatives covering EC reaction space to enzymes with mechanisms of interest to our users and collaborators with a view to exploring the chemical diversity of life. We present new tools for exploring the data in MACiE and comparing entries as well as new analyses of the data and new searches, many of which can now be accessed via dedicated Perl scripts.

9 December 2019 in European Geriatric Medicine
Verified
Journal Article
Open access
PDF file
SWSophie T. Williams
Sophie T. Williams
JDJugdeep K. Dhesi
Jugdeep K. Dhesi
JPJudith S. L. Partridge
Judith S. L. Partridge
Purpose: Delirium is a common clinical syndrome associated with increased physical and psychological morbidity, mortality, inpatient stay and healthcare costs. There is growing interest in understanding the delirium experience and its psychological impact, including distress, for patients and their relatives, carers and healthcare providers. Methods: This narrative review focuses on distress in delirium (DID) with an emphasis on its effect on older patients. It draws on qualitative and quantitative research to describe patient and environmental risk factors and variations in DID across a number of clinical settings, including medical and surgical inpatient wards and end of life care. The article provides an overview of the available distress assessment tools, both for clinical and research practice, and outlines their use in the context of delirium. This review also outlines established and emerging management strategies, focusing primarily on prevention and limitation of distress in delirium. Results: Both significant illness and delirium cause distress. Patients who recall the episode of delirium describe common experiential features of delirium and distress. Relatives who witness delirium also experience distress, at levels suggested to be greater than that experienced by patients themselves. DID results in long-term psychological sequelae that can last months and years. Preventative actions, such pre-episode educational information for patients and their families in those at risk may reduce distress and psychological morbidity. Conclusions: Improving clinicians’ understanding of the experience and long term psychological harm of delirium will enable the development of targeted support and information to patients at risk of delirium, and their families or carers.

3 October 2022 in Expert Reviews in Molecular Medicine
Verified
Journal Article
Open access
PDF file
SWSophie T. Williams
Sophie T. Williams
GWGreg Wells
Greg Wells
SCSamantha Conroy
Samantha Conroy
HGHannah Gagg
Hannah Gagg
RARichard Allen
Richard Allen
SDSarah Danson
Sarah Danson
Despite advances in cancer genomics and the increased use of genomic medicine, metastatic cancer is still mostly an incurable and fatal disease. With diminishing returns from traditional drug discovery strategies, and high clinical failure rates, more emphasis is being placed on alternative drug discovery platforms, such as ex vivo approaches. Ex vivo approaches aim to embed biological relevance and inter-patient variability at an earlier stage of drug discovery, and to offer more precise treatment stratification for patients. However, these techniques also have a high potential to offer personalised therapies to patients, complementing and enhancing genomic medicine. Although an array of approaches are available to researchers, only a minority of techniques have made it through to direct patient treatment within robust clinical trials. Within this review, we discuss the current challenges to ex vivo approaches within clinical practice and summarise the contemporary literature which has directed patient treatment. Finally, we map out how ex vivo approaches could transition from a small-scale, predominantly research based technology to a robust and validated predictive tool. In future, these pre-clinical approaches may be integrated into clinical cancer pathways to assist in the personalisation of therapy choices and to hopefully improve patient experiences and outcomes.

23 April 2018 in Chemical Science
Verified
Journal Article
Open access
PDF file
TMT. E. McAllister
T. E. McAllister
TYT.-L. Yeh
T.-L. Yeh
MAM. I. Abboud
M. I. Abboud
Ivanhoe LeungIvanhoe Leung
Ivanhoe Leung
EHE. S. Hookway
E. S. Hookway
AKAkane Kawamura
Akane Kawamura
Tight, non-active site binding cyclic peptides are promising affinity reagents for studying proteins and their interactions.